BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9240636)

  • 1. Reduction of radiation-induced xerostomia in nasopharyngeal carcinoma using CT simulation with laser patient marking and three-field irradiation technique.
    Nishioka T; Shirato H; Arimoto T; Kaneko M; Kitahara T; Oomori K; Yasuda M; Fukuda S; Inuyama Y; Miyasaka K
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):705-12. PubMed ID: 9240636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
    Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
    Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma.
    Wu VW; Ying MT; Kwong DL
    Br J Radiol; 2011 Sep; 84(1005):843-9. PubMed ID: 21224300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
    Gai X; Wei Y; Tao H; Zhu J; Li B
    Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.
    Cheng JC; Chao KS; Low D
    Int J Cancer; 2001 Apr; 96(2):126-31. PubMed ID: 11291096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
    Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
    Jen YM; Shih R; Lin YS; Su WF; Ku CH; Chang CS; Shueng PW; Hwang JM; Liu DW; Chao HL; Lin HY; Chang LP; Shum WY; Lin CS
    Radiother Oncol; 2005 May; 75(2):204-9. PubMed ID: 15908027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer.
    Marucci L; Marzi S; Sperduti I; Giovinazzo G; Pinnarò P; Benassi M; Strigari L
    Head Neck; 2012 Mar; 34(3):328-35. PubMed ID: 21400632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of late complications after irregularly shaped four-field whole pelvic radiotherapy using computed tomographic simulation compared with parallel-opposed whole pelvic radiotherapy.
    Yamazaki A; Shirato H; Nishioka T; Hashimoto S; Kitahara T; Kagei K; Miyasaka K
    Jpn J Clin Oncol; 2000 Apr; 30(4):180-4. PubMed ID: 10830986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rules of parotid gland dose variations and shift during intensity modulated radiation therapy for nasopharyngeal carcinoma.
    Wang W; Yang H; Mi Y; Hu W; Ding W; Xie Y; Cai Y; Chen X
    Radiat Oncol; 2015 Jan; 10():3. PubMed ID: 25566789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
    Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
    PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Parotid Glands on an Energy Spectrum CT Iodine Map to Evaluate Irradiation-Induced Acute Xerostomia in Patients With Nasopharyngeal Carcinoma.
    Chen R; Xie J; Chen J; Li X; Lin Q; Xu Q; Chen Y; Wang L; Zheng R; Xu B
    Technol Cancer Res Treat; 2024; 23():15330338241256814. PubMed ID: 38773777
    [No Abstract]   [Full Text] [Related]  

  • 17. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
    Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
    Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary effect of submandibular salivary gland transfer in preventing radiation-induced xerostomia of nasopharyngeal carcinoma].
    Liu XK; Zeng ZY; Hong MH; Cui NJ; Su Y; Mai HQ; Chen FJ
    Ai Zheng; 2005 May; 24(5):577-81. PubMed ID: 15890101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
    Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma.
    Jian JJ; Cheng SH; Prosnitz LR; Tsai SY; Tsai MJ; Huang AT
    Cancer; 1998 Jan; 82(2):261-7. PubMed ID: 9445180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.